GENMAB ASGENMAB ASGENMAB AS

GENMAB AS

No trades
See on Supercharts

Price target

6518.680.00 0.00%
The 21 analysts offering 1 year price forecasts for GMAB/N have a max estimate of — and a min estimate of —.

Analyst rating

Based on 27 analysts giving stock ratings to GMAB/N in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

GMAB/N EPS for the last quarter is 24.29 MXN despite the estimation of 54.11 MXN. In the next quarter EPS is expected to reach 28.54 MXN. Track more of GENMAB AS financials and stay on top of what is up with the company.
In the next quarter GENMAB AS revenue is expected to reach ‪9.50 B‬ MXN. Check out GENMAB AS revenue and earnings and make informed decisions.
According to analysts, GMAB/N price target is 6518.68 MXN with a max estimate of 8402.71 MXN and a min estimate of 4548.18 MXN. Check if this forecast comes true in a year, meanwhile keep track of the current situation with GMAB/N news and stock market news.
We've gathered opinions of 27 analysts rating GMAB/N stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.